Understanding antipsychotic “atypicality”: a clinical and pharmacological moving target

Por Remington, Gary
Publicado em 2003

Keep physicians' income in perspective

Por Remington, Gary
Publicado em 1995

Lithium treatment

Por Remington, Gary
Publicado em 1984

Extrapyramidal Side Effects

Por Remington, Gary
Publicado no Can J Psychiatry (2015)

168. Neuroadaptations to Antipsychotic Drugs: Optimizing use of Current Medication Through a Deeper Understanding of Antipsychotic Drug Action in the Brain and Body

Por Remington, Gary
Publicado no Schizophr Bull (2017)

Atypical antipsychotics : Patients value the lower incidence of extrapyramidial side effects

Por Kapur, Shitij, Remington, Gary
Publicado em 2000

Negative Symptoms in Schizophrenia: Avolition and Occam's Razor

Por Foussias, George, Remington, Gary
Publicado em 2010

Antipsychotic Dosing: How Much but also How Often?

Por Remington, Gary, Kapur, Shitij
Publicado em 2010

Interpreting a Multivariate Analysis of Functional Neuroimaging Data

Por Fervaha, Gagan, Remington, Gary
Publicado em 2012

Psychopharmacology for the Clinician

Por Remington, Gary, Hahn, Margaret
Publicado em 2014

Interventions to Reduce Weight Gain in Schizophrenia

Por Faulkner, Guy, Cohn, Tony, Remington, Gary
Publicado em 2007

Interventions to reduce weight gain in schizophrenia

Por Faulkner, Guy, Cohn, Tony, Remington, Gary
Publicado em 2007

Using Treatment Response to Subtype Schizophrenia: Proposal for a New Paradigm in Classification

Por Farooq, Saeed, Agid, Ofer, Foussias, George, Remington, Gary
Publicado em 2013

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

Por Takeuchi, Hiroyoshi, Suzuki, Takefumi, Remington, Gary, Uchida, Hiroyuki
Publicado no Can J Psychiatry (2015)

Practice and Learning: Spatiotemporal Differences in Thalamo-Cortical-Cerebellar Networks Engagement across Learning Phases in Schizophrenia

Por Korostil, Michele, Remington, Gary, McIntosh, Anthony Randal
Publicado no Front Psychiatry (2017)

Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia

Por Oh, Nicholas, See, Yuen Mei, Remington, Gary, Lee, Jimmy
Publicado no J Clin Psychopharmacol (2016)

2012 CCNP Innovations Award Paper: Antipsychotic dosing: found in translation

Por Remington, Gary, Fervaha, Gagan, Foussias, George, Agid, Ofer, Turrone, Peter
Publicado em 2014

Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis

Por Takeuchi, Hiroyoshi, Kantor, Navot, Uchida, Hiroyuki, Suzuki, Takefumi, Remington, Gary
Publicado no Schizophr Bull (2017)

Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis

Por Addington, Jean, Addington, Donald, Abidi, Sabina, Raedler, Thomas, Remington, Gary
Publicado no Can J Psychiatry (2017)

SA118. Intranasal Oxytocin Does Not Modulate Jumping to Conclusion: S in Schizophrenia: Potential Interaction With Baseline Social Functioning

Por Caravaggio, Fernando, Mar, Wanna, Remington, Gary, Graff-Guerrero, Ariel, Menon, Mahesh
Publicado no Schizophr Bull (2017)